-
Nurix Therapeutics, Sanofi Announce Development Collaboration
americanpharmaceuticalreview
January 15, 2020
Nurix Therapeutics announced a global strategic collaboration with Sanofi to discover, develop and commercialize a pipeline of targeted protein degradation drugs for patients with challenging diseases in multiple therapeutic areas.
-
Nuclear radiologists 'outsmart' prostate cancer with an apparently ineffective drug
worldpharmanews
January 14, 2020
When a non-scientist tries to imagine a scientist, the image that often arises is one of a somewhat remote, rather idealistic genius sitting alone in their room or laboratory and somehow discovering the most amazing things without every having contact wit
-
Schrödinger, Bayer collaborate to co-develop de novo design technology to accelerate drug discovery
americanpharmaceuticalreview
January 13, 2020
Schrödinger and Bayer announced a five-year technology alliance to develop a comprehensive de novo design solution with the objective to accelerate the discovery of innovative high-quality drugs.
-
Mercaptor Announces Epilepsy Preclinical Program
americanpharmaceuticalreview
January 13, 2020
Mercaptor Discoveries announced the advancement of its preclinical program in epilepsy. The program culminates in human trials, beginning in early 2022. Their primary candidate has demonstrated reproducible POC and efficacy in animal seizure models.
-
Governor of California proposes state-run drug label
europeanpharmaceuticalreview
January 13, 2020
In a bid to lower the costs of medicines, California’s governor has suggested contracting generic drug manufacturers to make pharmaceutical products for the state to sell, according to reports.
-
The Advance Value Framework: evaluating the benefits of novel medicines
europeanpharmaceuticalreview
January 09, 2020
Researchers have proven their methodology for drug benefit evaluation to be effective as a decision support tool in a study with several European drug evaluation bodies.
-
Cancer immunotherapy market to hit $115bn by 2023, says report
europeanpharmaceuticalreview
January 09, 2020
New research analysis has predicted that immunotherapy will become the oncology treatment of choice, with the market reaching $115 billion by 2023.
-
One Big Roadblock to Opioid Addiction Treatment
drugs
January 07, 2020
The crisis of opioid abuse continues in the United States. However, a new study finds there still aren't enough doctors authorized to prescribe the leading drug treatment for opioid addiction.
-
Three more companies raise their US drug list prices
europeanpharmaceuticalreview
January 07, 2020
Novartis, Merck and Allergan have joined numerous other pharmaceutical companies by increasing the price of certain drugs since the start of 2020.
-
U.S. Saw Big Rise in Meth, Fentanyl Use in 2019
drugs
January 06, 2020
A study of over 1 million urine drug tests from across the United States shows soaring rates of use of methamphetamines and fentanyl, often used together in potentially lethal ways.